Xcout Intel
Flashpoint Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Flashpoint Therapeutics among biotechnology companies — ranked by similarity to what Flashpoint Therapeutics actually does, not by market-cap band.
Subscribe to see Flashpoint Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Flashpoint Therapeutics
Flashpoint Therapeutics is a clinical-stage biotechnology research company headquartered in Evanston, Illinois, developing a new class of precision-engineered structural nanomedicines through its proprietary platform.
Flashpoint Therapeutics at a glance
Flashpoint Therapeutics is a biotechnology company headquartered in United States. Xcout tracks 8 named people at Flashpoint Therapeutics, including Barry Labinger (Chief Executive Officer).
Flashpoint Therapeutics leadership
- Barry LabingerChief Executive Officer
- Eric RowinskyConsulting Chief Medical Officer
- Venkat KrishnamurthyConsulting Chief Scientific Officer
- Chad MirkinScientific Founder Director, International Institute for Nanotechnology, Northwestern University
- Michelle Teplensky, PhDScientific Founder Assistant Professor of Chemical Engineering, Boston University
- Abdulrahman al Olayan, PhD, MBACEO & Managing Partner, Beta Lab
2 more named people on record for Flashpoint Therapeutics, with roles, board committees and tenure — see the full roster →
Top 12 Flashpoint Therapeutics competitors
Ranked by semantic similarity — how close each company is to Flashpoint Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Fulgent Pharma LLC is a clinical-stage pharmaceutical company that develops innovative cancer therapeutics using a patented nanoencapsulation technology. The company focuses on improving existing chemotherapy drugs and creating new drug candidates to treat various cancers while reducing toxicity and enhancing drug delivery and safety.
Similar biotechnology company
Matchpoint Therapeutics Inc. discovers and develops precision small molecule medicines utilizing covalent chemistry and chemoproteomics screening to treat immune diseases. The company leverages proprietary screening technologies and machine learning algorithms to expand the druggable proteome and design covalent drug candidates for patients with serious inflammatory and immune conditions.
Similar biotechnology company
BIND Therapeutics, Inc. is a clinical-stage nanomedicine company headquartered in Cambridge, Massachusetts. The company specializes in developing targeted and programmable therapeutics using its proprietary platform to treat various diseases.
Similar biotechnology company
Dewpoint Therapeutics is an integrated drug discovery platform company headquartered in Boston, Massachusetts. The firm leverages advanced biotechnology to translate condensate biology into novel medicines for various therapeutic areas.
Similar biotechnology company
Xanadu Bio, Inc. is a biotechnology company that develops next-generation polymer nanoparticle delivery platforms for mRNA and other nucleic acid-based therapies. Utilizing its proprietary poly(amine-co-ester) (PACE) polymer technology, the company creates tunable, organ-specific treatments for oncology and immunology, as well as intranasal vaccines for viral respiratory pathogens.
Similar biotechnology company
Phoreus Biotechnology, Inc. is a privately held biotechnology company founded in 2018 and headquartered in Olathe, Kansas. The company specializes in the development of proprietary nanocarriers for targeted drug delivery and enhanced treatments.
Biotech
Foghorn Therapeutics is a biopharmaceutical company headquartered in Watertown, Massachusetts. The company is pioneering a new class of medicines that treat serious diseases by leveraging insights into the chromatin regulatory system.
Similar biotechnology company
Aperture Therapeutics is a biotechnology research company founded in 2022 and headquartered in San Carlos, California. The company is building an innovative drug discovery platform that leverages patient genetic diversity and mechanistic insights.
Similar biotechnology company
RAPT Therapeutics is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. Founded in 2015, the public company leverages its proprietary drug discovery platform to develop treatments for inflammatory and immunologic diseases.
Biotech
Metaphore Biotechnologies, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, operating as part of Flagship Pioneering. The company focuses on therapeutic design, leveraging AI and machine learning technologies for drug discovery and development.
Biotech
Valerio Therapeutics is a biotechnology company that develops precision-guided therapeutics for complex and underserved diseases. It utilizes a proprietary V-Body conjugate platform, based on synthetic single-domain antibody libraries, to enable targeted drug delivery and deep tissue penetration.
Similar biotechnology company
Amphivena Therapeutics, Inc. is a privately held, clinical-stage biotechnology company based in South San Francisco, California. The company specializes in immuno-oncology, developing a platform of dual-function biologics and selective T cell engagers for the treatment of hematological conditions.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Flashpoint Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Flashpoint Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →